A trend to decrease in the astrogliosis marker GFAP was observed by western blot analysis in APPswe/PS1dE9 mice administered with FTY720, while no changes in the microglial marker IBA-1 were detected in AD mice upon FTY720 treatment (not shown). The gene discussed is GFAP; the disease is Alzheimer disease.